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Introduction
In locally advanced breast cancers one of the goals of
the neoadjuvant chemotherapy (NACT) is to convert
“inoperable” tumor into “operable” tumor (1). In the-
se patients NACT may allow an adequate control of the
disease impossible with surgery alone (2). Moreover, af-
ter NACT the patients may be treated with breast-con-
serving surgery (3). In the presence of inflammatory or
multifocal carcinoma, breast-conserving surgery is not
recommended and NACT has the only purpose of in-
creasing the survival of patients (4-10).
Patients  and methods
Between 2008 and 2012, we treated a total of 1040 patients with
breast cancer. Of these, 83 women were treated with NACT (Table
1). Chemotherapy schemes are anthracycline-based (until  8 cycles
in responsive patients).
Results
We evaluated the results of NACT in terms of type
of the subsequent surgery, i.e. conserving surgery (qua-
drantectomy or nipple-  and skin-sparing mastectomy)
versus  radical mastectomy, considering the post-NACT
tumor size (evaluated by imaging) as main factor in the
surgical decision.
In particular (Table 1):
- in 2008, 2 out of 7 patients treated with NACT
underwent to quadrantectomy and 5 patients to
radical mastectomy – In the two cases treated with
breast-conserving surgery following  NACT the
lesion was single with initial size of 3cm and a re-
sponse to chemotherapy by 80% (final size < 1cm).
In 3 of the 5 patients treated with radical ma-
stectomy the initial size of the tumor was more than
5cm; in the other two patients with multifocal car-
cinoma the conserving surgery was not applicable;
- in 2009, 11 patients were treated with NACT: five
of those underwent quadrantectomy (inclusion cri-
teria: size reduction of 60 -70% and free margins
at frozen section), while the remaining un-
derwent to radical mastectomy;
- in 2010, 8 out of 25 patients treated with
NACT underwent to conserving surgery (2 nip-
ple- and skin-sparing mastectomy, with histolo-
gical assessment of the retroareolar ducts; 6 qua-
drantectomy);
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- in 2011, 6 out of 17 patients with NACT un-
derwent to quadrantectomy, while the remaining
underwent to radical mastectomy;
- in 2012,  9 out of 23 patients treated with NACT
underwent conserving surgery (3 nipple- and skin-
sparing mastectomy; 9 quadrantectomy).
Between 2008 and 2012, in 16 out of 50 women trea-
ted with radical mastectomy the pre-NACT tumor ran-
ged between 2 and 4cm, and in 34 patients was > 4cm.
None of the patients with initial tumor size < 2cm was
treated with radical mastectomy (Table 2).
Discussion
Neoadjuvant chemotherapy is an important thera-
peutic approach to increase the chances of conserving sur-
gery (11-13). NACT results in a significant clinical re-
sponse in 90% of cases and complete in 25% of patients,
who are histologically confirmed in 4% of cases (14, 15).
If the conserving surgery is not recommended, NACT
retains a crucial role for the survival of the patient (16).
Key-points for eligibility to conserving surgery are the
size of the tumor (at least less than 5cm after-NACT),
single and well-defined lesion, genetics (absence of mu-
tations in the BRCA genes) (16, 17). Contraindications
to conserving surgery are multifocal breast carcinoma,
microcalcification spread, infiltration of the dermis,
lymphatic invasion, familiarity, and lobular carcinoma
(19). Patients with inflammatory carcinoma should be
treated with alternative chemotherapy regimens and/or
preoperative radiotherapy (18).
We preferred demolitive surgery in patients with post-
NACT tumor size between 3 and 5cm, multicentric can-
cer, or BRCA gene mutations (20-21).
Conclusion
The most clearly established advantage of neoadju-
vant chemotherapy is its ability to convert patients ini-
tially ineligible for breast conserving surgery into can-
didate for this treatment (21). 
Our preliminary results confirm that the neoadju-
vant chemotherapy increases the chances of breast-con-
serving surgery in patients with locally advanced can-
cer. We believe that the key of the successful breast-
conserving surgery after neoadjuvant chemotherapy are
the careful patients selection and coordination among
specialists.
TABLE 1 - TYPE OF SURGERY IN PATIENTS TREATED WITH NACT.
Legenda - NACT: patients treated with neoadjuvant chemotherapy;  Qu: quadrantectomy; NSS: nipple- and skin-sparing mastectomy;
RM: radical mastectomy. 
Patients/year, n 
2008 2009 2010 2011 2012
NACT (out of total) 7 (82) 11 (129) 25 (155) 17 (236) 23 (238)
Qu 2 5 6 6 9
NSSM 0 0 2 0 3
RM 5 6 17 11 11
TABLE 2 - TYPE OF SURGERY BY PRE-NEOADJUVANT
CHEMOTHERAPY (NACT) STAGE AND SIZE (T) OF THE
TUMOR.
Legenda - Qu: quadrantectomy; RM: radical mastectomy; NSSM:
nipple- and skin-sparing mastectomy.  
Pre-NACT characteristics Years 2008-2012
of the tumor
Qu RM NSSM 
(total 28) (total 50) (total 5)
Stage
IIA 10 2 3
IIB 9 5 2
IIIA 4 14 0
IIIB 0 29 0
T, cm
0-2 16 0 4
2.1-4 12 16 1
4.1-5 0 34 0
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